Skip to main content
Publications
Smith HE, Mackenzie AM, Seddon C , Mould R, Kalampouka I, Malakar P, Needham SR, Beis K, Bell JD, Nunn A, Botchway SW. The use of NADH anisotropy to investigate mitochondrial cristae alignment . Sci Rep. 2024 Mar 12;14(1):5980. doi: 10.1038/s41598-024-55780-5
Marti S, Carsin AE , Sampol J, Pallero M, Aldas I, Marin T, Lujan M, Lalmolda C, Sabater G, Bonnin-Vilaplana M, Penacoba P, Martinez-Llorens J, Tarrega J, Bernadich O, Cordoba-Izquierdo A, Lozano L, Mendez S, Velez-Segovia E, Prina E, Eizaguirre S, Balana-Corbero A, Ferrer J, Garcia-Aymerich J. Higher mortality and intubation rate in COVID-19 patients treated with noninvasive ventilation compared with high-flow oxygen or CPAP . Sci Rep. 2022 Apr 20;12(1):6527. doi: 10.1038/s41598-022-10475-7
Nixon E, Trickey A, Christensen H, Finn A, Thomas A, Relton C, Montgomery C, Hemani G, Metz J, Walker JG, Turner K, Kwiatkowska R, Sauchelli S , Danon L, Brooks-Pollock E. Contacts and behaviours of university students during the COVID-19 pandemic at the start of the 2020/2021 academic year . Sci Rep. 2021 Jun 3;11(1):11728. doi: 10.1038/s41598-021-91156-9
Accordini S, Calciano L, Marcon A, Pesce G, Anto JM, Beckmeyer-Borowko AB, Carsin AE , Corsico AG, Imboden M, Janson C, Keidel D, Locatelli F, Svanes C, Burney PGJ, Jarvis D, Probst-Hensch NM, Minelli C. Incidence trends of airflow obstruction among European adults without asthma: a 20-year cohort study . Sci Rep. 2020 Feb 26;10(1):3452. doi: 10.1038/s41598-020-60478-5
Rebordosa C , Houben E, Laugesen K, Bothner U, Montonen J, Aguado J , Overbeek JA, Ehrenstein V, Asmar J, Wallace L, Gilsenan AW . No evidence of off-label use of Olodaterol and Indacaterol in Denmark, France, and the Netherlands: a drug utilization study . Sci Rep. 2020 Jan 17;10(1):586. doi: 10.1038/s41598-019-57397-5
Steward T, Mestre-Bach G, Granero R, Sanchez I, Riesco N, Vintro-Alcaraz C, Sauchelli S , Jimenez-Murcia S, Aguera Z, Fernandez-Garcia JC, Garrido-Sanchez L, Tinahones FJ, Casanueva FF, Banos RM, Botella C, Crujeiras AB, Torre R, Fernandez-Real JM, Fruhbeck G, Ortega FJ, Rodriguez A, Menchon JM, Fernandez-Aranda F. Reduced plasma orexin-A concentrations are associated with cognitive deficits in anorexia nervosa . Sci Rep. 2019 May 27;9(1):7910. doi: 10.1038/s41598-019-44450-6
Montazeri P, Vrijheid M, Martinez D , Basterrechea M, Fernandez-Somoano A, Guxens M, Iniguez C, Lertxundi A, Murcia M, Tardon A, Sunyer J, Valvi D. Maternal metabolic health parameters during pregnancy in relation to early childhood BMI trajectories . Obesity (Silver Spring). 2018 Mar;26(3):588-96. doi: 10.1002/oby.22095
Yosipovitch G, Reaney M, Mastey V, Eckert L, Nelson L , Clark M , Abbe A, Ardeleanu M, Radin A, Gadkari A. Validation of the peak pruritus numerical rating scale: results from clinical studies of dupilumab in adults with moderate-to-severe atopic dermatitis . Poster presented at the 2017 American Academy of Dermatology Annual Meeting; March 4, 2017. Orlando, FL. [abstract] J Am Acad Dermatol. 2017 Jun; 76(6 Suppl 1):AB278. doi: 10.1016/j.jaad.2017.04.1082
Strober B, Gottlieb AB, Sherif B , Mollon P, Gilloteau I, McLeod L , Fox T, Mordin M , Gnanasakthy A , Papavassilis C, Lebwohl MG. Secukinumab sustains early patient-reported outcome benefits through 1 year: results from 2 phase III randomized placebo-controlled clinical trials comparing secukinumab with etanercept . J Am Acad Dermatol. 2017 Apr;76(4):655-61. doi: 10.1016/j.jaad.2016.11.043
Fagundo AB, Jimenez-Murcia S, Giner-Bartolome C, Aguera Z, Sauchelli S , Pardo M, Crujeiras AB, Granero R, Banos R, Botella C, de la Torre R, Fernandez-Real JM, Fernandez-Garcia JC, Fruhbeck G, Rodriguez A, Mallorqui-Bague N, Tarrega S, Tinahones FJ, Rodriguez R, Ortega F, Menchon JM, Casanueva FF, Fernandez-Aranda F. Modulation of irisin and physical activity on executive functions in obesity and morbid obesity . Sci Rep. 2016 Aug 1;6:30820. doi: 10.1038/srep30820
Robinson O, Martinez D , Aurrekoetxea JJ, Estarlich M, Somoano AF, Iniguez C, Santa-Marina L, Tardon A, Torrent M, Sunyer J, Valvi D, Vrijheid M. The association between passive and active tobacco smoke exposure and child weight status among Spanish children . Obesity (Silver Spring). 2016 Aug;24(8):1767-77. doi: 10.1002/oby.21558
Strober B, Blauvelt A, Zhao Y, Milutinovic M, Mollon P, You R, Sherif B , Williams N, Fox T, Augustin M, Lebwohl M. Secukinumab treatment provides more effective relief from patient-reported psoriasis-related pain, itching, and scaling than ustekinumab . Poster presented at the American Academy of Dermatology 74th Annual Meeting; March 4, 2016. Washington, DC. [abstract] J Am Acad Dermatol. 2016 May; 74(5 (Supplement 1)):AB273. Previously presented at the 24th European Academy of Dermatology and Venereology Congress. doi: 10.1016/j.jaad.2016.02.1054
Korman N, Sofen H, Rich P, Fretzin S, Zhao Y, Herrera V, Mordin M , Williams N, Nyirady J, Tyring S. Secukinumab provides more effective relief from psoriasis impact on personal relationships and influence on clothes worn than etanercept and placebo . Poster presented at the American Academy of Dermatology 74th Annual Meeting; March 4, 2016. Washington, DC. [abstract] J Am Acad Dermatol. 2016 May; 74(5 (Supplement 1)):AB272. doi: 10.1016/j.jaad.2016.02.1049
Tyring S, Sofen H, Fretzin S, Rich P, Zhao Y, Herrera V, Sherif B , Williams N, Nyirady J, Korman N. Secukinumab provides more effective relief from skin-related quality-of-life impact than etanercept in moderate to severe psoriasis . Poster presented at the American Academy of Dermatology 74th Annual Meeting; March 4, 2016. Washington, DC. [abstract] J Am Acad Dermatol. 2016 May; 74(5 (Supplement 1)):AB272. doi: 10.1016/j.jaad.2016.02.1050
Sofen H, Korman N, Rich P, Fretzin S, Zhao Y, Herrera V, Sherif B , McLeod L , Nyirady J, Tyring S. Secukinumab provides more effective relief from skin-related quality-of-life impact than placebo in moderate to severe psoriasis . Poster presented at the American Academy of Dermatology 74th Annual Meeting; March 4, 2016. Washington, DC. [abstract] J Am Acad Dermatol. 2016 May; 74(5 (Supplement 1)):AB272. doi: 10.1016/j.jaad.2016.02.1051
Blauvelt A, Korman N, Mollon P, Zhao Y, Milutinovic M, You R, Sherif B , Williams N, Fox T, Augustin M. Secukinumab treatment provides faster and more effective relief from patient-reported quality-of-life impact than ustekinumab in subjects with moderate to severe plaque psoriasis . Poster presented at the American Academy of Dermatology 74th Annual Meeting; March 4, 2016. Washington, DC. [abstract] J Am Acad Dermatol. 2016 May; 74(5[S1]):AB273. Previously presented at the 24th European Academy of Dermatology and Venereology Congress. doi: 10.1016/j.jaad.2016.02.1053
Kimball AB, Rothman KJ , Kricorian G, Pariser D, Yamauchi PS, Menter A, Teller CF, Aras G, Accortt NA, Hooper M, Rice KC, Gelfand JM. OBSERVE-5: observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results . J Am Acad Dermatol. 2015 Jan;72(1):115-22. doi: 10.1016/j.jaad.2014.08.050
Valvi D, Mendez MA, Garcia-Esteban R , Ballester F, Ibarluzea J, Goni F, Grimalt JO, Llop S, Marina LS, Vizcaino E, Sunyer J, Vrijheid M. Prenatal exposure to persistent organic pollutants and rapid weight gain and overweight in infancy . Obesity (Silver Spring). 2014 Feb;22(2):488-96. doi: 10.1002/oby.20603